Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
On track to report topline data from Phase 2 TRANQUILITY trial in first half of 2025 – – Assembled Cardiovascular Scientific Advisory Board (CV SAB), comprised of leading academic and industry experts ...
HME News1d
RESNA accepting papers
RESNA is accepting scientific papers and student scientific papers for its conference, May 13 - 15, 2025, as part of RehabWeek 2025 Chicago.
Business Wire1d
Global Healthy Living Foundation Brings Innovative and Patient-Centered Polymyalgia Rheumatica, Psoriatic, and Rheumatoid Arthritis Research to ACR Conv…
Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...
GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024
Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with ...
Business Insider2d
Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
will deliver a poster presentation at the ACR Convergence 2024 Annual Meeting, which will be held in Washington, D.C., November 14-19, 2024. A copy of the Company’s presentation will be available ...